NCT00231920View on ClinicalTrials.gov

Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

October 31, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Fluzone

Trial Locations (2)

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

37232-2573

Vanderbilt University, Nashville

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00231920 - Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age | Biotech Hunter | Biotech Hunter